首页 > 最新文献

Klinicheskaia meditsina最新文献

英文 中文
[EVALUATION OF BODY MASS INDICES AND ARTERIAL PRESSURE AS CARDIOVASCULAR RISK FACTORS IN THE ADULT POPULATION OF THE CITY OF VORONEZH]. [评价沃罗涅日市成人体重指数和动脉压作为心血管危险因素]。
Pub Date : 2017-01-01
A V Kryuchkova, N M Seminina, Yu V Kondusova, I A Poletaeva, A M Knyazeva

Aim: To determine body mass index (BMI) and blood pressure (BP) of the Voronezh city adult population.

Materials and methods: 1108 residents of Voronezh city at the age from 20 to 75 years were examined in 2015 including measurement of their height, body mass, arterial pressure, and BMI calculation. Medical histories were analyzed to reveal arterial hypertension in the preceding period in the following age groups: 20-29, 30-39, 40-49, 50-59, 60-75 yr and the entire study group (20-75 yr).

Results: The mean BMI of the residents of Voronezh was 28.5 (23.8; 33.1) kg/m. The highest values were found between 40 and 59 years. BMI in women under 40 was lower than in men of the same age. The education level affected the prevalence of obesity in that people with secondary vocational education were more likely to be obese than those given higher education. At the age of 40, the incidence of hypertension among women was lower than among men of the same age, it more frequently occurred at the age of 60-75 years. Both age and BMI were related to the level of blood pressure: higher BMI and blood pressure were recorded at an older age. The prevalence of hypertension also increased with age.

Conclusion: Obesity was detected in 29.7% of the Voronezh population recruited to the study. The prevalence of obesity among young adults (20-29 years) iproved lower than in the middle and old age groups. 30.9% of the residents suffered from AH.

目的:测定沃罗涅日市成人体质指数(BMI)和血压(BP)。材料和方法:2015年对沃罗涅日市1108名年龄在20 - 75岁之间的居民进行了调查,包括测量他们的身高、体重、动脉压和BMI计算。分析病史以揭示以下年龄组的前期动脉高血压:20-29岁、30-39岁、40-49岁、50-59岁、60-75岁和整个研究组(20-75岁)。结果:沃罗涅日居民平均BMI为28.5 (23.8;33.1公斤/米。在40岁到59岁之间发现了最高的数值。40岁以下女性的身体质量指数低于同龄男性。受教育程度影响肥胖的流行程度,中等职业教育的人比受过高等教育的人更容易肥胖。40岁时,女性高血压发病率低于同龄男性,60-75岁多见。年龄和身体质量指数都与血压水平有关:年龄越大,身体质量指数和血压越高。高血压患病率也随着年龄的增长而增加。结论:参与研究的沃罗涅日人群中有29.7%检测到肥胖。年轻人(20-29岁)肥胖患病率的改善程度低于中老年人群。30.9%的居民患有AH。
{"title":"[EVALUATION OF BODY MASS INDICES AND ARTERIAL PRESSURE AS CARDIOVASCULAR RISK FACTORS IN THE ADULT POPULATION OF THE CITY OF VORONEZH].","authors":"A V Kryuchkova,&nbsp;N M Seminina,&nbsp;Yu V Kondusova,&nbsp;I A Poletaeva,&nbsp;A M Knyazeva","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To determine body mass index (BMI) and blood pressure (BP) of the Voronezh city adult population.</p><p><strong>Materials and methods: </strong>1108 residents of Voronezh city at the age from 20 to 75 years were examined in 2015 including measurement of their height, body mass, arterial pressure, and BMI calculation. Medical histories were analyzed to reveal arterial hypertension in the preceding period in the following age groups: 20-29, 30-39, 40-49, 50-59, 60-75 yr and the entire study group (20-75 yr).</p><p><strong>Results: </strong>The mean BMI of the residents of Voronezh was 28.5 (23.8; 33.1) kg/m. The highest values were found between 40 and 59 years. BMI in women under 40 was lower than in men of the same age. The education level affected the prevalence of obesity in that people with secondary vocational education were more likely to be obese than those given higher education. At the age of 40, the incidence of hypertension among women was lower than among men of the same age, it more frequently occurred at the age of 60-75 years. Both age and BMI were related to the level of blood pressure: higher BMI and blood pressure were recorded at an older age. The prevalence of hypertension also increased with age.</p><p><strong>Conclusion: </strong>Obesity was detected in 29.7% of the Voronezh population recruited to the study. The prevalence of obesity among young adults (20-29 years) iproved lower than in the middle and old age groups. 30.9% of the residents suffered from AH.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 2","pages":"148-53"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36560662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[DIAGNOSTIC SIGNIFICANCE OF PLASMA TROPONIN AND CARDIOMYOCYTE FATTY ACID-BINDING PROTEIN LEVELS IN ACUTE CORONARY SYNDROME]. 血浆肌钙蛋白和心肌细胞脂肪酸结合蛋白水平对急性冠脉综合征的诊断意义。
Pub Date : 2017-01-01 DOI: 10.18821/0023-2149-2017-95-3-207-215
V. Titov
Blood serum content of fatty acid-binding (FABP) protein increases within 2-3 h after the onset of acute coronary syndrome and myocardial infarction (MI) and reaches the maximum 8.5 h after the initiation of cardiomyocyte death. FABP content considerably decreases by the end of at 24-h period due to excretion with urine, remaining elevated for subsequent 24 h. High clinical sensitivity and relatively high organ specificity are typical of FABP for 12 h after ACS. Within the early period of MI clinical specificity of FABP prevails over troponin in terms of concentration. Troponins display higher clinical sensitivity and diagnostic specificity during a 12-h period after ACS, prevailing for several days after MI. Simultaneous measuring of FABP and troponins (Tr) within the first 12 h increases the sensitivity of biochemical diagnostics by 30%. At later periods, simultaneous determination of FABP and Tr becomes unnecessary: FABP is excreted with urine and Tr level acquires predominant diagnostic significance. No relationship has been revealed between blood content of FABP and reperfusion according to electrocardiography data, probably due to rare measurements of this highly dynamic parameter. FABP test cannot be used in patients with circulatory disorders since its results are not adequate. The best option for differential diagnostics of ACS within the first 24 h would be a combined express immunochromatographic test which allows to measure blood FABP and Tr levels pending objective evaluation.
血清脂肪酸结合蛋白(FABP)含量在急性冠状动脉综合征和心肌梗死(MI)发病后2 ~ 3 h内升高,在心肌细胞死亡开始后8.5 h达到最大值。由于随尿排出,FABP含量在24小时结束时显著降低,并在随后的24小时内保持升高。在ACS后12小时内,FABP具有较高的临床敏感性和相对较高的器官特异性。在心肌梗死早期,FABP的临床特异性高于肌钙蛋白的浓度。肌钙蛋白在ACS后的12小时内表现出更高的临床敏感性和诊断特异性,在心肌梗死后的几天内普遍存在。在前12小时内同时测量FABP和肌钙蛋白(Tr)可使生化诊断的敏感性提高30%。在晚期,同时测定FABP和Tr就没有必要了:FABP随尿排出,而Tr水平具有主要的诊断意义。根据心电图数据,没有发现血中FABP含量与再灌注之间的关系,可能是由于很少测量这一高度动态的参数。FABP试验不能用于循环系统疾病患者,因为其结果不充分。在最初24小时内鉴别诊断ACS的最佳选择是联合表达免疫层析测试,该测试允许在客观评估之前测量血液FABP和Tr水平。
{"title":"[DIAGNOSTIC SIGNIFICANCE OF PLASMA TROPONIN AND CARDIOMYOCYTE FATTY ACID-BINDING PROTEIN LEVELS IN ACUTE CORONARY SYNDROME].","authors":"V. Titov","doi":"10.18821/0023-2149-2017-95-3-207-215","DOIUrl":"https://doi.org/10.18821/0023-2149-2017-95-3-207-215","url":null,"abstract":"Blood serum content of fatty acid-binding (FABP) protein increases within 2-3 h after the onset of acute coronary syndrome and myocardial infarction (MI) and reaches the maximum 8.5 h after the initiation of cardiomyocyte death. FABP content considerably decreases by the end of at 24-h period due to excretion with urine, remaining elevated for subsequent 24 h. High clinical sensitivity and relatively high organ specificity are typical of FABP for 12 h after ACS. Within the early period of MI clinical specificity of FABP prevails over troponin in terms of concentration. Troponins display higher clinical sensitivity and diagnostic specificity during a 12-h period after ACS, prevailing for several days after MI. Simultaneous measuring of FABP and troponins (Tr) within the first 12 h increases the sensitivity of biochemical diagnostics by 30%. At later periods, simultaneous determination of FABP and Tr becomes unnecessary: FABP is excreted with urine and Tr level acquires predominant diagnostic significance. No relationship has been revealed between blood content of FABP and reperfusion according to electrocardiography data, probably due to rare measurements of this highly dynamic parameter. FABP test cannot be used in patients with circulatory disorders since its results are not adequate. The best option for differential diagnostics of ACS within the first 24 h would be a combined express immunochromatographic test which allows to measure blood FABP and Tr levels pending objective evaluation.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"19 1","pages":"207-15"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81651213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[ZIKA FEVER: CLINICAL, EPIDEMIOLOGICAL, LABORATORY, AND DIAGNOSTIC ASPECTS]. [寨卡热:临床、流行病学、实验室和诊断方面]。
Pub Date : 2017-01-01 DOI: 10.18821/0023-2149-2017-95-2-112-117
K. Zhdanov, S. Zakharenko, A. Kovalenko, A. Semenov, S. Kozlov, A. Fisun
The authors overview data on the prevalence of Zika fever with reference to biological properties of the causative agent, epidemiological process, pathogenesis, and clinical symptoms of the disease. Special attention is given to the identification of the virus in pregnant women, microcephaly in the babies born by Zika-infected women, algorithm of laboratory diagnostics, and measures needed to prevent and control mosquitoes that spread viruses.
作者从病原体的生物学特性、流行病学过程、发病机制和寨卡热的临床症状等方面综述了寨卡热的流行情况。特别关注孕妇体内病毒的鉴定、感染寨卡病毒的妇女所生婴儿的小头畸形、实验室诊断算法以及预防和控制传播病毒的蚊子所需的措施。
{"title":"[ZIKA FEVER: CLINICAL, EPIDEMIOLOGICAL, LABORATORY, AND DIAGNOSTIC ASPECTS].","authors":"K. Zhdanov, S. Zakharenko, A. Kovalenko, A. Semenov, S. Kozlov, A. Fisun","doi":"10.18821/0023-2149-2017-95-2-112-117","DOIUrl":"https://doi.org/10.18821/0023-2149-2017-95-2-112-117","url":null,"abstract":"The authors overview data on the prevalence of Zika fever with reference to biological properties of the causative agent, epidemiological process, pathogenesis, and clinical symptoms of the disease. Special attention is given to the identification of the virus in pregnant women, microcephaly in the babies born by Zika-infected women, algorithm of laboratory diagnostics, and measures needed to prevent and control mosquitoes that spread viruses.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"6 1","pages":"112-7"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75618594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[TRENDS IN DEVELOPMENT OF GI-SAFE ANTI-INFLAMMATORY DRUGS]. [gi安全抗炎药的发展趋势]。
Pub Date : 2017-01-01 DOI: 10.18821/0023-2149-2017-95-3-222-227
O. Sulaieva, J. Wallace
Despite the introduction of anti-inflammatory drugs that selectively inhibit cyclo-oxygenase-2 (COX-2), and potent inhibitors of gastric acid secretion, the gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) remain a significant clinical problem. Combined use of antisecretory drugs and COX-2 inhibitors is helpful to limit the damage in the proximal gastrointestinal tract (stomach and duodenum), but it increases the risk of injury of small intestine and colon. It was proven that proton pump inhibitors and H2 receptor antagonists significantly worsen NSAID-induced small intestinal damage and microbiota balance. Nowadays, there is no proven effective preventative or curative treatment for NSAID-induced enteropathy. The new strategy of gastrointestinal protection is based on the discovery of endogenous cytoprotective molecules such as hydrogen sulfide (H₂S). H2S is a gaseous mediator that produces strong cytoprotective and antioxidant effect on the gastrointestinal tract. The role of H₂S in promoting mucosal integrity, healing of tissue injury and resolution of inflammation has been well documented. In addition, H₂S stimulates productions of other cytoprotective molecules including prostaglandins, carbon monoxide and nitric oxide. Nowadays, the new generation of H₂S-releasing non-steroidal anti-inflammatory drugs is developed and tested in clinical trials. H₂S-NSAIDs possess enhanced anti-inflammatory activity and high gastrointestinal safety.
尽管引入了选择性抑制环氧化酶-2 (COX-2)和强效胃酸分泌抑制剂的抗炎药物,但非甾体抗炎药(NSAIDs)的胃肠道不良反应仍然是一个重要的临床问题。联合使用抗分泌药物和COX-2抑制剂有助于限制近端胃肠道(胃和十二指肠)的损伤,但增加了小肠和结肠损伤的风险。事实证明,质子泵抑制剂和H2受体拮抗剂显著加重nsaid诱导的小肠损伤和微生物群平衡。目前,对于非甾体抗炎药引起的肠病,尚无有效的预防或治疗方法。新的胃肠保护策略是基于发现内源性细胞保护分子,如硫化氢(H₂S)。H2S是一种气体介质,对胃肠道具有很强的细胞保护和抗氧化作用。h2s在促进粘膜完整性、组织损伤愈合和炎症消退中的作用已被充分证实。此外,h2s还会刺激前列腺素、一氧化碳和一氧化氮等其他细胞保护分子的产生。目前,新一代释放H₂s的非甾体抗炎药正在开发和临床试验中。H₂S-NSAIDs具有较强的抗炎活性和较高的胃肠道安全性。
{"title":"[TRENDS IN DEVELOPMENT OF GI-SAFE ANTI-INFLAMMATORY DRUGS].","authors":"O. Sulaieva, J. Wallace","doi":"10.18821/0023-2149-2017-95-3-222-227","DOIUrl":"https://doi.org/10.18821/0023-2149-2017-95-3-222-227","url":null,"abstract":"Despite the introduction of anti-inflammatory drugs that selectively inhibit cyclo-oxygenase-2 (COX-2), and potent inhibitors of gastric acid secretion, the gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) remain a significant clinical problem. Combined use of antisecretory drugs and COX-2 inhibitors is helpful to limit the damage in the proximal gastrointestinal tract (stomach and duodenum), but it increases the risk of injury of small intestine and colon. It was proven that proton pump inhibitors and H2 receptor antagonists significantly worsen NSAID-induced small intestinal damage and microbiota balance. Nowadays, there is no proven effective preventative or curative treatment for NSAID-induced enteropathy. The new strategy of gastrointestinal protection is based on the discovery of endogenous cytoprotective molecules such as hydrogen sulfide (H₂S). H2S is a gaseous mediator that produces strong cytoprotective and antioxidant effect on the gastrointestinal tract. The role of H₂S in promoting mucosal integrity, healing of tissue injury and resolution of inflammation has been well documented. In addition, H₂S stimulates productions of other cytoprotective molecules including prostaglandins, carbon monoxide and nitric oxide. Nowadays, the new generation of H₂S-releasing non-steroidal anti-inflammatory drugs is developed and tested in clinical trials. H₂S-NSAIDs possess enhanced anti-inflammatory activity and high gastrointestinal safety.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"5 5 1","pages":"222-7"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83607675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
[TYPICAL ERRORS IN THERAPY OF GASTROESOPHAGEAL REFLUX DISEASE]. [胃食管反流病治疗的典型错误]。
Pub Date : 2017-01-01 DOI: 10.18821/0023-2149-2017-95-2-163-167
M. Chikunova, I. Khlynov, D. V. Khromtsova
Aim To analyze compliance of doctors with the clinical guidelines for the management of patients with gastroesophageal reflux disease (GERD) under outpatient clinic conditions. Material and methods An anonymous questionnaire study involving 104 general practitioners was undertaken. The questionnaires included items concerning lifestyle modifications, the use of proton pump inhibitors (PPI), dosage and time of their administration, combined therapy and endoscopic control. Results The analysis of the filled questionnaires demonstrated that 15,6% of the doctors always discuss the necessity changing lifestyle with GERD patients, 75% of the doctors discuss it but occasionally, and 9,4% never hold such discussions. 56,7% of the doctors begin treatment from double doses of proton pump inhibitors regardless of the endoscopic stage of esophagus damage. The mode of PPI administration is at variance with that recommended by the instruction in 61,5% of the cases. The basic course of erosive esophagitis treatment lasts 4, 2, and 8 weeks in 45,2%, 9,6%, and 45,2% of the cases. Treatment of GERD starts from combined therapy in 14,4% of the cases. Monotherapy with PPI is inefficient in 85,6% of the cases. Endoscopic control of erosive esophagitis is practiced by 51,9% of the doctors, 48,1% of the respondents recommend this diagnostic procedure only in the absence of clinical effect. Conclusion Our analysis revealed typical mistakes in the treatment of patients with GERD, demonstrated the importance of expert control and support of training physicians, and introduction of modern quality standards into the practical management of patients with this pathology.
目的分析门诊条件下医生对胃食管反流病(GERD)临床治疗指南的依从性。材料与方法对104名全科医生进行匿名问卷调查。问卷内容包括生活方式的改变、质子泵抑制剂(PPI)的使用、给药剂量和时间、联合治疗和内镜控制。结果对问卷的分析显示,15.6%的医生经常与胃食管反流患者讨论改变生活方式的必要性,75%的医生偶尔讨论,9.4%的医生从不讨论。56.7%的医生从双剂量质子泵抑制剂开始治疗,无论食管损伤的内镜阶段如何。在61.5%的病例中,PPI给药方式与说明书推荐的不一致。糜烂性食管炎的基本疗程为4周、2周和8周,分别占45.2%、9.6%和45.2%。在14.4%的病例中,胃反流的治疗从联合治疗开始。在85.6%的病例中,单用PPI治疗无效。51.9%的医生采用内镜控制糜烂性食管炎,48.1%的应答者仅在没有临床效果的情况下才推荐这种诊断方法。结论我们的分析揭示了胃食管反流患者治疗中的典型错误,证明了专家控制和培训医师支持的重要性,并将现代质量标准引入到该病理患者的实际管理中。
{"title":"[TYPICAL ERRORS IN THERAPY OF GASTROESOPHAGEAL REFLUX DISEASE].","authors":"M. Chikunova, I. Khlynov, D. V. Khromtsova","doi":"10.18821/0023-2149-2017-95-2-163-167","DOIUrl":"https://doi.org/10.18821/0023-2149-2017-95-2-163-167","url":null,"abstract":"Aim To analyze compliance of doctors with the clinical guidelines for the management of patients with gastroesophageal reflux disease (GERD) under outpatient clinic conditions. Material and methods An anonymous questionnaire study involving 104 general practitioners was undertaken. The questionnaires included items concerning lifestyle modifications, the use of proton pump inhibitors (PPI), dosage and time of their administration, combined therapy and endoscopic control. Results The analysis of the filled questionnaires demonstrated that 15,6% of the doctors always discuss the necessity changing lifestyle with GERD patients, 75% of the doctors discuss it but occasionally, and 9,4% never hold such discussions. 56,7% of the doctors begin treatment from double doses of proton pump inhibitors regardless of the endoscopic stage of esophagus damage. The mode of PPI administration is at variance with that recommended by the instruction in 61,5% of the cases. The basic course of erosive esophagitis treatment lasts 4, 2, and 8 weeks in 45,2%, 9,6%, and 45,2% of the cases. Treatment of GERD starts from combined therapy in 14,4% of the cases. Monotherapy with PPI is inefficient in 85,6% of the cases. Endoscopic control of erosive esophagitis is practiced by 51,9% of the doctors, 48,1% of the respondents recommend this diagnostic procedure only in the absence of clinical effect. Conclusion Our analysis revealed typical mistakes in the treatment of patients with GERD, demonstrated the importance of expert control and support of training physicians, and introduction of modern quality standards into the practical management of patients with this pathology.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"292 1","pages":"163-7"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79513649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A critical incident during marathon competition as a result of metabolic decompensation]. [马拉松比赛中因代谢失代偿引起的严重事件]。
Pub Date : 2017-01-01
Yu P Orlov, N V Govorova, A V Glushchenko, E N Efremov, Yu B Vasilenko

A case of polyorganic insufficiency syndrome associated with coma, convulsive disorder, acute hepato-renal and respiratory dysfunction, hypovolemic shock, and hyperthermal syndrome in a 46 year-old participant ofa marathon competition is reported. The clinical picture was dominated by acute hepatic insufficiency treated with remaxol to activate substrate phosphorylation under effect of exogenous succinate for slowing down the development of energy deficit in mitochondria under condition of oxygen deficit. This case can be regarded as a variant of correction of mitochondrial dysfunction with the use of a mitochondria-targeted medication such as succinate-containing remaxol. This medication reduced AST and ALT activities and utilization of endogenous enzymes for succinate synthesis from alanine and aspartate under hypoxic conditions. Prescription of remaxol as a form of direct substitution therapy was dictated by pathogenetic considerations.

本文报告了一例46岁马拉松比赛参与者的多器官功能不全综合征,并伴有昏迷、惊厥障碍、急性肝肾和呼吸功能障碍、低血容量性休克和高热综合征。临床表现以急性肝功能不全为主,在外源性琥珀酸盐的作用下,用利马索激活底物磷酸化,以减缓缺氧条件下线粒体能量缺陷的发展。这种情况可以被视为线粒体功能障碍的一种变体,使用线粒体靶向药物,如含琥珀酸的利美索。该药物降低了缺氧条件下丙氨酸和天冬氨酸合成琥珀酸的内源性酶的利用率和AST和ALT活性。处方雷马索作为一种形式的直接替代治疗是由致病因素决定的。
{"title":"[A critical incident during marathon competition as a result of metabolic decompensation].","authors":"Yu P Orlov,&nbsp;N V Govorova,&nbsp;A V Glushchenko,&nbsp;E N Efremov,&nbsp;Yu B Vasilenko","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A case of polyorganic insufficiency syndrome associated with coma, convulsive disorder, acute hepato-renal and respiratory dysfunction, hypovolemic shock, and hyperthermal syndrome in a 46 year-old participant ofa marathon competition is reported. The clinical picture was dominated by acute hepatic insufficiency treated with remaxol to activate substrate phosphorylation under effect of exogenous succinate for slowing down the development of energy deficit in mitochondria under condition of oxygen deficit. This case can be regarded as a variant of correction of mitochondrial dysfunction with the use of a mitochondria-targeted medication such as succinate-containing remaxol. This medication reduced AST and ALT activities and utilization of endogenous enzymes for succinate synthesis from alanine and aspartate under hypoxic conditions. Prescription of remaxol as a form of direct substitution therapy was dictated by pathogenetic considerations.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 1","pages":"85-9"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36557490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Therapeutic Monitoring Plasma Imatinib to Improve Results of the Treatment of Chronic Myeloleukosis]. [监测血浆伊马替尼改善慢性骨髓白化症的治疗效果]。
Pub Date : 2017-01-01
M I Savelyeva, A V Kryukov

The achievement of early cytogenetic and molecular responses is the major objective of therapy and a main prerequisite for the favourable long-term outcome of the disease. The maintenance of dose intensity and management of adverse events are keys to successful treatment of chronic myeloid leukemia (CML) with imatinib. Therapeutic monitoring and testing the drug level in blood are the efficient tools for the treatment of patients with CML and can be usedfor analysis of treatment failure or suboptimal response to therapy, suspected noncompliance, drug interactions or unexpected adverse reactions.

实现早期细胞遗传学和分子反应是治疗的主要目标,也是该疾病良好长期预后的主要先决条件。维持剂量强度和不良事件的管理是伊马替尼治疗慢性髓性白血病(CML)成功的关键。治疗监测和检测血液中药物水平是治疗CML患者的有效工具,可用于分析治疗失败或治疗次优反应,怀疑不依从性,药物相互作用或意外不良反应。
{"title":"[Therapeutic Monitoring Plasma Imatinib to Improve Results of the Treatment of Chronic Myeloleukosis].","authors":"M I Savelyeva,&nbsp;A V Kryukov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The achievement of early cytogenetic and molecular responses is the major objective of therapy and a main prerequisite for the favourable long-term outcome of the disease. The maintenance of dose intensity and management of adverse events are keys to successful treatment of chronic myeloid leukemia (CML) with imatinib. Therapeutic monitoring and testing the drug level in blood are the efficient tools for the treatment of patients with CML and can be usedfor analysis of treatment failure or suboptimal response to therapy, suspected noncompliance, drug interactions or unexpected adverse reactions.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 1","pages":"36-44"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36568654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Obesity and cardiovascular system]. 肥胖和心血管系统。
Pub Date : 2017-01-01
A F Verbovoy, A V Pashentseva, L A Sharonova

Obesity is a serious medico-social and economic problem. Increased body mass index is associated with a rise in the general mortality rate and mortality due to cardiovascular diseases. In this article, modern views of the influence of obesity on the cardiovascular system are considered.

肥胖是一个严重的医学、社会和经济问题。体重指数的增加与一般死亡率和心血管疾病死亡率的上升有关。在这篇文章中,肥胖对心血管系统影响的现代观点被考虑。
{"title":"[Obesity and cardiovascular system].","authors":"A F Verbovoy,&nbsp;A V Pashentseva,&nbsp;L A Sharonova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Obesity is a serious medico-social and economic problem. Increased body mass index is associated with a rise in the general mortality rate and mortality due to cardiovascular diseases. In this article, modern views of the influence of obesity on the cardiovascular system are considered.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 1","pages":"31-5"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36568659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[THE ROLE OF LOW-FREQUENCY PIEZOTHROMBOELASTOGRAPHY IN THE COMPREHENSIVE EVALUATION OF HEMOSTASIS IN CORONARY BYPASS SURGERY WITH CARDIOPULMONARY BYPASS]. [低频压电血栓弹性成像在冠状动脉搭桥术合并体外循环止血的综合评价中的作用]。
Pub Date : 2017-01-01
E V Fanaskova, O V Gruzdeva, O E Akbasheva, I I Tyutrin, T Yu Penskaya, E G Uchasova, G P Plotnikov, K E Krivoshapova, O L Barbarash

Aim: To monitor the hemostatic system during platelet concentrate transfusions using low-frequency piezothromboelastography in patients with coronary bypass surgery given aspirin therapy.

Materials and methods: The study involved 148 patients with coronary bypass surgery, with 76 ones undergoing intraoperative transfusion of platelet concentrate and 72 treated without transfusion. The control group consisted of 20 healthy individuals. In the perioperative period indicators of vascular-platelet, coagulation, anticoagulant and fibrinolytic components of hemostasis were evaluated by low-frequency pezotromboelastography using the ARP-01M "Mednord" hardware and software system (Russia).

Results: It was shown that the antiplatelet effect of aspirin in the preoperative period was manifest as inhibition of the initial stage of blood coagulation accompanied by increased thrombin potential, the total gain of anticoagulant and fibrinolytic activity of the blood. Heart-lung bypass was accompanied by structural and chronometric anticoagulation, reduction of anticoagulation and increase of blood fibrinolytic activity. In the postoperative period, structural and chronometric anticoagulation was more pronounced in patients who did not undergo transfusion of platelet concentrate than in the group of patients with transfusion. Donor platelets further increased the blood hemostatic potential by neutralizing the antiplatelet effect of aspirin. Perioperative thrombohemorrhagic complications were absent in both groups.

Conclusion: Low-frequency piezothromboelastography provides a tool for real-time monitoring the functional state of hemostasis system. Transfusion of platelet concentrate is not advisable given that the thrombin potential is preserved as confirmed by the results of low-frequency piezothromboelastography.

目的:应用低频血栓弹性成像技术监测冠状动脉搭桥术后给予阿司匹林治疗的患者血小板浓缩输注时的止血系统。材料与方法:本研究纳入148例冠状动脉搭桥术患者,术中输注浓缩血小板76例,未输注血小板72例。对照组由20名健康个体组成。围手术期血管血小板、凝血、抗凝、纤溶等止血指标采用俄罗斯美诺公司ARP-01M软硬件系统进行低频血小板弹性成像评估。结果:术前阿司匹林的抗血小板作用表现为抑制凝血初始阶段,同时伴有凝血酶电位升高,血液抗凝和纤溶活性总增加。体外循环伴结构性和时度性抗凝,抗凝功能降低,血纤溶活性升高。术后未输注浓缩血小板的患者比输注浓缩血小板的患者结构抗凝和计时抗凝更为明显。供体血小板通过中和阿司匹林的抗血小板作用进一步增加血液的止血潜能。两组患者围手术期均无血栓出血性并发症。结论:低频血栓弹性成像为实时监测止血系统功能状态提供了一种工具。输血血小板浓缩物是不可取的,因为凝血酶的潜力被保留,由低频压电血栓弹性成像的结果证实。
{"title":"[THE ROLE OF LOW-FREQUENCY PIEZOTHROMBOELASTOGRAPHY IN THE COMPREHENSIVE EVALUATION OF HEMOSTASIS IN CORONARY BYPASS SURGERY WITH CARDIOPULMONARY BYPASS].","authors":"E V Fanaskova,&nbsp;O V Gruzdeva,&nbsp;O E Akbasheva,&nbsp;I I Tyutrin,&nbsp;T Yu Penskaya,&nbsp;E G Uchasova,&nbsp;G P Plotnikov,&nbsp;K E Krivoshapova,&nbsp;O L Barbarash","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To monitor the hemostatic system during platelet concentrate transfusions using low-frequency piezothromboelastography in patients with coronary bypass surgery given aspirin therapy.</p><p><strong>Materials and methods: </strong>The study involved 148 patients with coronary bypass surgery, with 76 ones undergoing intraoperative transfusion of platelet concentrate and 72 treated without transfusion. The control group consisted of 20 healthy individuals. In the perioperative period indicators of vascular-platelet, coagulation, anticoagulant and fibrinolytic components of hemostasis were evaluated by low-frequency pezotromboelastography using the ARP-01M \"Mednord\" hardware and software system (Russia).</p><p><strong>Results: </strong>It was shown that the antiplatelet effect of aspirin in the preoperative period was manifest as inhibition of the initial stage of blood coagulation accompanied by increased thrombin potential, the total gain of anticoagulant and fibrinolytic activity of the blood. Heart-lung bypass was accompanied by structural and chronometric anticoagulation, reduction of anticoagulation and increase of blood fibrinolytic activity. In the postoperative period, structural and chronometric anticoagulation was more pronounced in patients who did not undergo transfusion of platelet concentrate than in the group of patients with transfusion. Donor platelets further increased the blood hemostatic potential by neutralizing the antiplatelet effect of aspirin. Perioperative thrombohemorrhagic complications were absent in both groups.</p><p><strong>Conclusion: </strong>Low-frequency piezothromboelastography provides a tool for real-time monitoring the functional state of hemostasis system. Transfusion of platelet concentrate is not advisable given that the thrombin potential is preserved as confirmed by the results of low-frequency piezothromboelastography.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 3","pages":"245-53"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36570424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[RESEARCH ON THE LEVEL, COMPONENTS AND THE TYPE OF COOPERATIVITY IN THE PATIENTS WITH ASTHMA]. [哮喘患者协同性水平、成分及类型的研究]。
Pub Date : 2017-01-01
L V Bogovin

The patient’s cooperativity is the major factor which determines the patient’s adherence to doctor’s prescriptions and, consequently, the achievement of disease control. We proposed the “Evaluation of the cooperativity in asthma” questionnaire to evaluate the level, components and types of cooperativity in 141 patients with the mixed or atopic form of asthma (94.3 and 5.7%, respectively) at admission to hospital who were aware about their disease. The analysis of investigated parameters depending on the level of patients’ awareness of their condition (according to the “Awareness of patients about asthma” test), severity and duration of the disease, presence of alexithymia and social and economic index was done. It was found out that patients with asthma exaggerate the degree of their compliance. The general indices of cooperativity (GIC=58.1±7.3%) and understanding of danger (35.8±3.3%) in the patients who were aware about their disease were low. Qualitative characteristics of individual cooperativity components in examined patients are presented. Nearly 76% of the patients showed negative cooperativity inversely correlating with the severity of asthma and the duration of the disease. Positive cooperativity appeared to be directly related with the higher educational level, occupation and higher income level of the patients. Generally speaking, low average GIC ratings and low patients’ adherence to asthma treatment suggest their low cooperativity.

患者的配合是决定患者是否遵守医生处方,从而实现疾病控制的主要因素。我们提出了“哮喘协同性评价”问卷,评估141例混合或特应性哮喘患者(分别为94.3%和5.7%)入院时对自己的疾病知情的协同性水平、组成部分和类型。根据患者对其病情的认识程度(根据“患者对哮喘的认识”测试)、疾病的严重程度和持续时间、有无述情障碍以及社会和经济指数对调查参数进行分析。研究发现,哮喘患者会夸大他们的依从性。知病患者的总体配合性指数(GIC=58.1±7.3%)和对危险的认识指数(35.8±3.3%)较低。在检查的病人的个人合作成分的定性特征提出。近76%的患者表现出负的协同性,与哮喘的严重程度和病程呈负相关。积极合作与患者的高学历、职业和高收入水平有直接关系。一般来说,较低的平均GIC评分和较低的患者对哮喘治疗的依从性表明他们的合作程度较低。
{"title":"[RESEARCH ON THE LEVEL, COMPONENTS AND THE TYPE OF COOPERATIVITY IN THE PATIENTS WITH ASTHMA].","authors":"L V Bogovin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The patient’s cooperativity is the major factor which determines the patient’s adherence to doctor’s prescriptions and, consequently, the achievement of disease control. We proposed the “Evaluation of the cooperativity in asthma” questionnaire to evaluate the level, components and types of cooperativity in 141 patients with the mixed or atopic form of asthma (94.3 and 5.7%, respectively) at admission to hospital who were aware about their disease. The analysis of investigated parameters depending on the level of patients’ awareness of their condition (according to the “Awareness of patients about asthma” test), severity and duration of the disease, presence of alexithymia and social and economic index was done. It was found out that patients with asthma exaggerate the degree of their compliance. The general indices of cooperativity (GIC=58.1±7.3%) and understanding of danger (35.8±3.3%) in the patients who were aware about their disease were low. Qualitative characteristics of individual cooperativity components in examined patients are presented. Nearly 76% of the patients showed negative cooperativity inversely correlating with the severity of asthma and the duration of the disease. Positive cooperativity appeared to be directly related with the higher educational level, occupation and higher income level of the patients. Generally speaking, low average GIC ratings and low patients’ adherence to asthma treatment suggest their low cooperativity.</p>","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"95 3","pages":"254-9"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36570428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinicheskaia meditsina
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1